Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Dipiproverine hydrochloride
RN: 2404-18-4
UNII: 8UYY5B89ZU
InChIKey: CBACFHTXHGHTMH-UHFFFAOYSA-N

Molecular Formula

  • C20-H30-N2-O2.2Cl-H

Molecular Weight

  • 403.391
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Dipiproverine dihydrochloride
  • Dipiproverine hydrochloride

Synonyms

  • 1-Piperidine-ethanol alpha-phenyl-1-piperidineacetate ester, as dihydrochloride
  • alpha-Phenyl-1-piperidineacetic acid 2-piperidinoethyl ester dihydrochloride
  • alpha-Phenyl-alpha-piperidinoacetic acid beta-piperidinoethyl ester hydrochloride
  • beta-Piperidinoethyl alpha-phenyl-alpha-piperidinoacetate dihydrochloride
  • Dichlorhydrate de dipiproverine
  • Dichlorhydrate de dipiproverine [French]
  • Dipiproverine HCl
  • Dipiproverine hydrochloride
  • EINECS 219-293-3
  • L.D. 935
  • LD 935
  • Levospasme
  • Piperidinoethyl alpha-piperidinophenylacetate dihydrochloride
  • Spasmonal
  • UNII-8UYY5B89ZU

Systematic Names

  • 1-(alpha-(2-Piperidinioethoxycarbonyl)benzyl)piperidinium dichloride
  • 1-Piperidineacetic acid, alpha-phenyl-, 2-piperidinoethyl ester, dihydrochloride
  • 1-Piperidineethanol, alpha-phenyl-1-piperidineacetate (ester), dihydrochloride

Registry Numbers

CAS Registry Number

  • 2404-18-4

FDA UNII

  • 8UYY5B89ZU

Other Registry Number

  • 79433-03-7

System Generated Number

  • 0002404184

Molecular Formulas

Molecular Formula

  • C20-H30-N2-O2.2Cl-H

Molecular Formula Fragments

  • C20-H30-N2-O2
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C20H30N2O2.2ClH/c23-20(24-17-16-21-12-6-2-7-13-21)19(18-10-4-1-5-11-18)22-14-8-3-9-15-22;;/h1,4-5,10-11,19H,2-3,6-9,12-17H2;2*1H

InChIKey

CBACFHTXHGHTMH-UHFFFAOYSA-N

Smiles

c1(ccccc1)[C@@H](C(OCCN1CCCCC1)=O)N1CCCCC1.Cl.Cl

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
guinea pig LD50 intravenous 131mg/kg (131mg/kg)   Therapie. Vol. 14, Pg. 731, 1959.
mouse LD50 intravenous 80mg/kg (80mg/kg)   Therapie. Vol. 14, Pg. 731, 1959.
mouse LD50 oral 1100mg/kg (1100mg/kg)   Therapie. Vol. 14, Pg. 731, 1959.
mouse LD50 subcutaneous 950mg/kg (950mg/kg)   Therapie. Vol. 14, Pg. 731, 1959.
rat LD50 intraperitoneal 550mg/kg (550mg/kg)   Pharmazie. Vol. 11, Pg. 261, 1956.
rat LD50 oral 2gm/kg (2000mg/kg)   Pharmazie. Vol. 11, Pg. 261, 1956.